Thursday, June 9, 2016

BRIEF-Theravance Biopharma posts positive results from early-stage trial of Ulcerative Colitis drug

* Reports positive results from phase 1 clinical trial of

TD-1473, a GI-targeted Pan-Janus Kinase (JAK) inhibitor

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)